NPI: 1265497226 · SOUTHFIELD, MI 48075 · Pediatrics Physician · NPI assigned 04/20/2006
Authorized official STARKEL, SARAH controls 20+ related entities in our dataset. Read more
| Authorized Official | STARKEL, SARAH (CREDENTIALING COORDINATOR) |
| NPI Enumeration Date | 04/20/2006 |
Other providers sharing the same authorized official: STARKEL, SARAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,793 | $378K |
| 2019 | 17,512 | $394K |
| 2020 | 13,081 | $312K |
| 2021 | 14,307 | $373K |
| 2022 | 27,254 | $416K |
| 2023 | 34,508 | $518K |
| 2024 | 21,949 | $488K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13,962 | 11,907 | $834K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5,620 | 5,602 | $431K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5,855 | 5,773 | $409K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 13,157 | 13,051 | $289K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3,785 | 3,783 | $284K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3,185 | 2,987 | $266K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2,135 | 2,132 | $174K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3,456 | 2,906 | $33K |
| 92587 | 2,459 | 2,454 | $24K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,696 | 1,637 | $21K |
| 83655 | 1,779 | 1,759 | $19K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 697 | 661 | $17K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,274 | 1,272 | $12K |
| 96127 | 2,914 | 2,798 | $8K | |
| 99177 | 5,526 | 5,510 | $8K | |
| 88720 | 2,525 | 1,297 | $7K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 169 | 165 | $7K |
| 81002 | 2,464 | 2,438 | $6K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 50 | 50 | $6K |
| 99460 | 84 | 82 | $4K | |
| 85018 | 1,987 | 1,976 | $4K | |
| 99051 | 404 | 389 | $3K | |
| 99381 | 24 | 24 | $2K | |
| 36416 | 1,368 | 1,356 | $2K | |
| 90480 | 30 | 30 | $1K | |
| 90677 | 733 | 732 | $1K | |
| 0072A | 21 | 21 | $804.30 | |
| 0071A | 17 | 17 | $658.57 | |
| 96380 | 31 | 31 | $646.41 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 61 | 59 | $525.98 |
| 81003 | 324 | 314 | $507.96 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 13 | 13 | $407.45 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 34 | 30 | $366.17 |
| G0008 | Administration of influenza virus vaccine | 18 | 18 | $200.05 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 12 | 12 | $87.15 |
| 94760 | 2,883 | 2,528 | $65.62 | |
| 90686 | 5,486 | 5,473 | $48.52 | |
| 90661 | 374 | 374 | $38.69 | |
| 90461 | 1,024 | 1,012 | $7.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 16 | 12 | $1.88 |
| 98967 | 13 | 13 | $0.02 | |
| 90633 | 1,882 | 1,870 | $0.00 | |
| 90707 | 783 | 783 | $0.00 | |
| 90700 | 481 | 481 | $0.00 | |
| 90715 | 101 | 101 | $0.00 | |
| 90710 | 325 | 324 | $0.00 | |
| 90670 | 3,245 | 3,236 | $0.00 | |
| 1159F | 8,890 | 7,557 | $0.00 | |
| 90734 | 710 | 708 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 67 | 66 | $0.00 |
| 1160F | 8,889 | 7,557 | $0.00 | |
| 3078F | 3,342 | 3,318 | $0.00 | |
| 90380 | 14 | 14 | $0.00 | |
| 91321 | 26 | 26 | $0.00 | |
| 90744 | 2,133 | 2,124 | $0.00 | |
| 3074F | 3,362 | 3,337 | $0.00 | |
| 90647 | 591 | 589 | $0.00 | |
| 90680 | 2,798 | 2,789 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 2,196 | 2,189 | $0.00 |
| 90698 | 2,999 | 2,991 | $0.00 | |
| 90381 | 32 | 32 | $0.00 | |
| 90716 | 754 | 752 | $0.00 | |
| 90696 | 360 | 359 | $0.00 | |
| 1036F | 3,376 | 3,127 | $0.00 | |
| 90651 | 631 | 631 | $0.00 | |
| 3008F | 6,471 | 6,405 | $0.00 | |
| 90620 | 269 | 267 | $0.00 | |
| 1126F | 2,961 | 2,854 | $0.00 | |
| 91307 | 13 | 13 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 13 | 12 | $0.00 |
| 90674 | 25 | 25 | $0.00 |